| 1 |
34622970 | Primary cutaneous anaplastic large-cell lymphoma with DUSP22-IRF4 rearrangement following insect bites. | 2022 Feb |
1 |
| 2 |
35044836 | TRAIL Score: A Simple Model to Predict Immunochemotherapy Tolerability in Patients With Diffuse Large B-Cell Lymphoma. | 2022 Jan |
1 |
| 3 |
35210509 | Comprehensive geriatric assessment as a useful tool in predicting adverse events in elderly patients with diffuse large B-cell lymphoma. | 2022 Feb 24 |
1 |
| 4 |
35218445 | Resistance to obinutuzumab-induced antibody-dependent cellular cytotoxicity caused by abnormal Fas signaling is overcome by combination therapies. | 2022 Feb 26 |
1 |
| 5 |
35220927 | BR (bendamustine plus rituximab) versus R-CHOP for patients with indolent B-cell lymphomas: a systematic review and Meta-analysis. | 2022 Feb 26 |
1 |
| 6 |
35297262 | Colonic infiltration of chronic lymphocytic leukemia with Hodgkin Reed Sternberg-like cells. | 2022 Mar 17 |
1 |
| 7 |
35478137 | Evaluation of Medication Instruction Sheets for Patients Undergoing R-CHOP Therapy in Non-Hodgkin's Lymphoma. | 2022 May-Jun |
1 |
| 8 |
35545831 | Peripheral T-Cell Lymphoma Presenting as a Scalp Mass. | 2022 Apr |
1 |
| 9 |
34610523 | Blastoid variant of mantle cell lymphoma in palatine tonsil. | 2021 Nov |
1 |
| 10 |
34661507 | Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone therapy increases carotid intima-media thickness and plaque score with von Willebrand factor activity elevation in patients with malignant lymphoma. | 2021 Oct 18 |
1 |
| 11 |
34745610 | Intratumoral T-cell receptor repertoire is predictive of interim PET scan results in patients with diffuse large B-cell lymphoma treated with rituximab/cyclophosphamide/doxorubicin/prednisolone/vincristine (R-CHOP) chemoimmunotherapy. | 2021 |
2 |
| 12 |
34765356 | Vincristine-Induced Bilateral Vocal Cord Palsy in an Adult Male With Diffuse Large B-Cell Lymphoma. | 2021 Oct |
1 |
| 13 |
34895738 | Complete response in a frail patient with high-grade B-cell lymphoma to only one cycle of R-CHOP or to prolonged COVID-19? | 2021 Aug-Dec |
1 |
| 14 |
34990525 | Pegfilgrastim Prophylaxis is Effective in the Prevention of Febrile Neutropenia and Reduces Mortality in Patients Aged ≥75 Years with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Prospective Cohort Study. | 2021 Dec 30 |
1 |
| 15 |
32349779 | CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trial. | 2020 Apr 30 |
2 |
| 16 |
32529585 | Impact of prednisolone dosage in the CHOP regimen for follicular lymphoma: a retrospective study. | 2020 Sep |
2 |
| 17 |
32643971 | Chidamide combined with ibrutinib improved the prognosis of primary bone marrow diffuse large B cell lymphoma. | 2020 Jul |
1 |
| 18 |
32915975 | Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphoma. | 2020 Sep 22 |
1 |
| 19 |
33093947 | ACCEPT - combining acalabrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) for Diffuse Large B-cell Lymphoma (DLBCL): study protocol for a Phase Ib/II open-label non-randomised clinical trial. | 2020 |
2 |
| 20 |
33468831 | [A Case of Peritoneal Lymphomatosis Diagnosed by Laparoscopic Biopsy]. | 2020 Dec |
1 |
| 21 |
30581162 | Multicenter Phase 2 Study of Reduced-Dose CHOP Chemotherapy Combined With Rituximab for Elderly Patients With Diffuse Large B-Cell Lymphoma. | 2019 Mar |
1 |
| 22 |
31151970 | Paraneoplastic erythroderma: unusual presentation secondary to diffuse large B cell lymphoma. | 2019 May 30 |
1 |
| 23 |
31222719 | Stand-alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R-CHOP and is associated increased infection-related toxicity. | 2019 Oct |
1 |
| 24 |
31723484 | Primary Central Nervous System Lymphoma
with Peripheral Nerve Involvement:
Case Report. | 2019 Sep 16 |
1 |
| 25 |
31832222 | Granisetron plus aprepitant versus granisetron in preventing nausea and vomiting during CHOP or R-CHOP regimen in malignant lymphoma: a retrospective study. | 2019 |
2 |
| 26 |
29467881 | Diffuse large B-cell lymphoma: 10 years' real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone. | 2018 Mar |
1 |
| 27 |
29618689 | [Osteonecrosis developing after rituximab-containing chemotherapy for Waldenström macroglobulinemia]. | 2018 |
1 |
| 28 |
29719411 | Forodesine in the treatment of relapsed/refractory peripheral T-cell lymphoma: an evidence-based review. | 2018 |
1 |
| 29 |
30241515 | PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivity. | 2018 Sep 21 |
1 |
| 30 |
30314526 | Operative R0 resection of diffuse large B-cell lymphoma of the pelvis: a case report. | 2018 Oct 13 |
2 |
| 31 |
30431571 | Relapsed subcutaneous panniculitis-like T cell lymphoma evaluated by FDG PET/CT: A clinical case report. | 2018 Nov |
1 |
| 32 |
26449182 | CHOP or THP-COP regimens in the treatment of newly diagnosed peripheral T-cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin. | 2017 Jun |
1 |
| 33 |
27253186 | Clinical case report: a rare cause of acute kidney failure - tissue is the issue. | 2017 Jun |
1 |
| 34 |
27283030 | Human Herpesvirus 8-Unrelated Primary Effusion Lymphoma-Like Lymphoma in an Elderly Korean Patient with a Good Response to Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone. | 2017 Jan |
1 |
| 35 |
27736260 | R-CHOP(-like) treatment of diffuse large B-cell lymphoma significantly reduces CT-assessed vertebral bone density: a single center study of 111 patients. | 2017 May |
1 |
| 36 |
27928587 | Prognosis of patients with peripheral T cell lymphoma who achieve complete response after CHOP/CHOP-like chemotherapy without autologous stem cell transplantation as an initial treatment. | 2017 Mar |
1 |
| 37 |
28458356 | Control of Constipation in Patients Receiving CHOP or CHOP-Like Chemotherapy Regimens for Non-Hodgkin's Lymphoma. | 2017 |
1 |
| 38 |
28725323 | The Elevation of Cardio-Ankle Vascular Index in a Patient With Malignant Lymphoma Treated With a Combination Therapy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone. | 2017 Aug |
1 |
| 39 |
28978846 | Molecular pathogenesis and treatment strategy in diffuse large B-cell lymphoma. | 2017 |
1 |
| 40 |
29279550 | Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects. | 2017 |
1 |
| 41 |
29333403 | Treatment outcomes of dose-attenuated CHOP chemotherapy in elderly patients with peripheral T cell lymphoma. | 2017 Dec |
1 |
| 42 |
26506947 | Paraneoplastic pemphigus associated with fatal bronchiolitis obliterans and intractable mucosal erosions: Treatment with cyclosporin in addition to steroid, rituximab and intravenous immunoglobulin. | 2016 Apr |
1 |
| 43 |
26764304 | [Intravascular Large B Cell Lymphoma with Cauda Equina Syndrome: A Case Report and Review of the Literature]. | 2016 Jan |
1 |
| 44 |
26834485 | ALK-positive anaplastic large cell lymphoma with prominent bone involvement in a 13-year-old boy. | 2016 |
1 |
| 45 |
26990931 | Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14). | 2016 May |
1 |
| 46 |
27073670 | Chemotherapy continuity and incidence of febrile neutropenia with CHOP therapy in an outpatient setting. | 2016 Apr |
1 |
| 47 |
27477167 | Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) in the management of primary mediastinal B-cell lymphoma: a subgroup analysis of the UK NCRI R-CHOP 14 versus 21 trial. | 2016 Nov |
1 |
| 48 |
27530021 | [REACTIVATION OF TUBERCULOSIS PRESENTING WITH EMPYEMA DUE TO ANTICANCER CHEMOTHERAPY FOR DIFFUSE LARGE B CELL LYMPHOMA]. | 2016 Apr |
1 |
| 49 |
25430047 | Prognostic impact of the TP53 rs1625895 polymorphism in DLBCL patients. | 2015 Apr |
1 |
| 50 |
26370464 | Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphoma. | 2015 Sep 14 |
1 |